Completed NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors NCT04332653 Conditions Adnexal Diseases, Any Advanced Solid Tumors, Breast Diseases, +41 more Locations Moffit Cancer Center — Tampa, Florida, United States Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States Washington University School of Medicine in St. Louis — St Louis, Missouri, United States Duke University Medical Center — Durham, North Carolina, United States View more locations Show fewer locations Loading locations... View Trial Details
